Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Myocardial aging as a T-cell-mediated phenomenon.
Ramos GC, van den Berg A, Nunes-Silva V, Weirather J, Peters L, Burkard M, Friedrich M, Pinnecker J, Abeßer M, Heinze KG, Schuh K, Beyersdorf N, Kerkau T, Demengeot J, Frantz S, Hofmann U. Ramos GC, et al. Among authors: weirather j. Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2420-E2429. doi: 10.1073/pnas.1621047114. Epub 2017 Mar 2. Proc Natl Acad Sci U S A. 2017. PMID: 28255084 Free PMC article.
CD4+ Foxp3+ T-cells contribute to myocardial ischemia-reperfusion injury.
Mathes D, Weirather J, Nordbeck P, Arias-Loza AP, Burkard M, Pachel C, Kerkau T, Beyersdorf N, Frantz S, Hofmann U. Mathes D, et al. Among authors: weirather j. J Mol Cell Cardiol. 2016 Dec;101:99-105. doi: 10.1016/j.yjmcc.2016.10.007. Epub 2016 Oct 19. J Mol Cell Cardiol. 2016. PMID: 27771254
Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
Li X, Bauer W, Israel I, Kreissl MC, Weirather J, Richter D, Bauer E, Herold V, Jakob P, Buck A, Frantz S, Samnick S. Li X, et al. Among authors: weirather j. Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1661-7. doi: 10.1161/ATVBAHA.114.303485. Epub 2014 Jun 5. Arterioscler Thromb Vasc Biol. 2014. PMID: 24903095
Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study.
Salles G, Duell J, González Barca E, Tournilhac O, Jurczak W, Liberati AM, Nagy Z, Obr A, Gaidano G, André M, Kalakonda N, Dreyling M, Weirather J, Dirnberger-Hertweck M, Ambarkhane S, Fingerle-Rowson G, Maddocks K. Salles G, et al. Among authors: weirather j. Lancet Oncol. 2020 Jul;21(7):978-988. doi: 10.1016/S1470-2045(20)30225-4. Epub 2020 Jun 5. Lancet Oncol. 2020. PMID: 32511983 Clinical Trial.
Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma.
Duell J, Maddocks KJ, González-Barca E, Jurczak W, Liberati AM, De Vos S, Nagy Z, Obr A, Gaidano G, Abrisqueta P, Kalakonda N, André M, Dreyling M, Menne T, Tournilhac O, Augustin M, Rosenwald A, Dirnberger-Hertweck M, Weirather J, Ambarkhane S, Salles G. Duell J, et al. Among authors: weirather j. Haematologica. 2021 Sep 1;106(9):2417-2426. doi: 10.3324/haematol.2020.275958. Haematologica. 2021. PMID: 34196165 Free PMC article. Clinical Trial.
52 results